| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-807-01 | 59651-807 | HUMAN PRESCRIPTION DRUG | MECLIZINE HYDROCHLORIDE | MECLIZINE | TABLET | ORAL | 20230914 | N/A | ANDA | ANDA202640 | Aurobindo Pharma Limited | MECLIZINE HYDROCHLORIDE | 12.5 mg/1 | 100 TABLET in 1 BOTTLE (59651-807-01) |
| 59651-807-99 | 59651-807 | HUMAN PRESCRIPTION DRUG | MECLIZINE HYDROCHLORIDE | MECLIZINE | TABLET | ORAL | 20230914 | N/A | ANDA | ANDA202640 | Aurobindo Pharma Limited | MECLIZINE HYDROCHLORIDE | 12.5 mg/1 | 1000 TABLET in 1 BOTTLE (59651-807-99) |
| 59651-808-01 | 59651-808 | HUMAN PRESCRIPTION DRUG | MECLIZINE HYDROCHLORIDE | MECLIZINE | TABLET | ORAL | 20230914 | N/A | ANDA | ANDA202640 | Aurobindo Pharma Limited | MECLIZINE HYDROCHLORIDE | 25 mg/1 | 100 TABLET in 1 BOTTLE (59651-808-01) |
| 59651-808-99 | 59651-808 | HUMAN PRESCRIPTION DRUG | MECLIZINE HYDROCHLORIDE | MECLIZINE | TABLET | ORAL | 20230914 | N/A | ANDA | ANDA202640 | Aurobindo Pharma Limited | MECLIZINE HYDROCHLORIDE | 25 mg/1 | 1000 TABLET in 1 BOTTLE (59651-808-99) |
| 59651-809-05 | 59651-809 | HUMAN PRESCRIPTION DRUG | MECLIZINE HYDROCHLORIDE | MECLIZINE | TABLET | ORAL | 20230914 | N/A | ANDA | ANDA202640 | Aurobindo Pharma Limited | MECLIZINE HYDROCHLORIDE | 50 mg/1 | 500 TABLET in 1 BOTTLE (59651-809-05) |
| 59651-809-90 | 59651-809 | HUMAN PRESCRIPTION DRUG | MECLIZINE HYDROCHLORIDE | MECLIZINE | TABLET | ORAL | 20230914 | N/A | ANDA | ANDA202640 | Aurobindo Pharma Limited | MECLIZINE HYDROCHLORIDE | 50 mg/1 | 90 TABLET in 1 BOTTLE (59651-809-90) |